Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1324 of 6351
-
New cortisol timing therapy may improve life for adults with rare hormone disorder
Disease control Not yet recruitingClassic congenital adrenal hyperplasia (CAH) is an autosomal recessive genetic disorder caused by a defect in the enzyme cascade regulating adrenal steroidogenesis; in approximately 95% of cases the defect is located in CYP21A2, the gene encoding 21-hydroxylase, and is characteri…
Sponsor: IRCCS San Raffaele • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
A simple blood test trend may flag ICU patients at risk
Knowledge-focused CompletedThe goal of this observational study is to evaluate if early absolute hemoglobin decline (during the first 24 hours of admission) can predict prolonged intensive care unit stay (8 days or more) and in-hospital mortality in critically ill adult patients. The main questions it aim…
Sponsor: Hospital H+ Queretaro • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Can Real-World data uncover hidden risks of the Alzheimer's drug LEQEMBI?
Knowledge-focused Not yet recruitingTo describe the incidence and severity of known adverse events, including amyloid-related imaging abnormalities-edema (ARIA-E), ARIA microhemorrhage and hemosiderin deposit (ARIA-H), and intracerebral hemorrhage greater than 1 cm in diameter in participants treated with LEQEMBI d…
Sponsor: Eisai Limited • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
New ADHD assessment system could sharpen diagnosis in kids
Diagnosis Not yet recruitingThis clinical trial aims to evaluate the diagnostic efficacy and safety of the Attention Deficit Hyperactivity Disorder Assessment System (AHEF) in children aged 6 to 12 in China, while ensuring the safety of the subjects and maintaining the scientific integrity of the clinical t…
Sponsor: Chongqing Jinsaixing Medical Technology Co., Ltd • Aim: Diagnosis
Last updated Jul 31, 2026 00:00 UTC
-
Could a single pill tame bipolar depression and obesity together?
Disease control Not yet recruitingThis research study examines how a medication called lumateperone may affect mood symptoms, and inflammation in adults with bipolar disorder over approximately 6 weeks. An MRI scan to calculate biological age of the brain will also be obtained at the start of the study.
Phase 4 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New antibody drug targets Hard-to-Treat cancers
Disease control Recruiting nowThis study is an open-label, multicenter, non-randomized Phase I clinical study with dose-escalation and expansion cohorts, designed to evaluate the safety, tolerability, pharmacokinetic characteristics, and preliminary efficacy of SI-B036 bispecific antibody injection in patient…
Phase 1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new capsule ease bone metastasis pain without opioids?
Symptom relief Not yet recruitingThis is a randomized, double-blind, placebo-controlled Phase Ib study evaluating the safety and efficacy of VC004 capsules for the relief of moderate-to-severe pain associated with bone metastases
Phase 1 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Wall squats tested as a blood pressure hack for sleep apnea patients
Disease control Recruiting nowThis study will look at whether a simple exercise called the isometric wall squat can help lower blood pressure in adults who have both hypertension and obstructive sleep apnoea treated with CPAP. Obstructive sleep apnoea is a condition in which breathing repeatedly stops or beco…
Sponsor: Aveiro University • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Video games and AI join the fight against a rare movement disorder
Knowledge-focused Not yet recruitingFriedreich ataxia (FA) is a rare, inherited condition that progressively affects balance, coordination, and walking. Clinical trials of new FA treatments rely largely on standard clinical rating scales, but these can be tiring for patients, feel disconnected from everyday life, a…
Sponsor: University of Exeter • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC
-
Can a simple drug stop nausea during emergency C-Sections?
Disease control Recruiting nowThe aim of this prospective randomized double-blind study is to compare the effectiveness of routine antiemetic prophylaxis for the prevention of intraoperative nausea and vomiting (IONV) in non-fasted parturients undergoing emergency cesarean section under spinal anesthesia. Na…
Phase 4 • Sponsor: Sanliurfa Education and Research Hospital • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
Can a herbal bath cut Post-Surgery painkiller use?
Symptom relief Not yet recruitingBackground:Perianal abscess is a common acute anorectal pyogenic disease (8%-25% of anorectal illnesses), mainly seen in men aged 20-40. Over 90% suffer severe postoperative pain, impairing healing, triggering anxiety or sepsis and raising medical loads. Western multimodal analge…
Sponsor: The Affiliated Hospital of Putian University • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Can a new pain drug safely team up with an opioid?
Disease control Not yet recruitingThis study will evaluate the drug-drug interaction between KL0011034 Injection and Alfentanil Hydrochloride Injection in participants with moderate-to-severe non-cancer chronic pain. The study consists of two parts. Part 1 is a single-center, randomized, open-label, parallel-desi…
Phase 1 • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated Aug 09, 2026 00:00 UTC
-
Ancient wisdom meets modern care: could chinese medicine boost diabetes Self-Management?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if a Chinese medicine diabetes education programme is feasible and acceptable, and to explore its preliminary effects on self-management, for adults with type 2 diabetes in Hong Kong. The main questions it aims to answer are: 1. Is the…
Sponsor: The Hong Kong Polytechnic University • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
Can brain scans predict dementia risk in Late-Life depression?
Knowledge-focused By invitation onlyThe goal of this observational study is to learn about the long-term effects of late-life depression (LLD) in adults aged 60 and older. LLD is depression that begins for the first time later in life. Patients with this condition may feel sad for a long time or lose interest in ac…
Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
New drug aims to build muscle in rare muscular dystrophy
Disease control Recruiting nowA randomized Phase 2 study to evaluate the efficacy and safety of apitegromab as a monotherapy in participant with FSHD
Phase 2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
A Self-Applied numbing cream might take the sting out of IUD insertion
Symptom relief Not yet recruitingThe aim of this study is to determine if 5g of self-administered topical 2.5% lidocaine/2.5% prilocaine cream, reduces pain during IUD insertion and/or endometrial biopsy. The proposed study is a double-blind, placebo-controlled RCT. Each participant will be randomly assigned to …
Sponsor: Mount Sinai Hospital, Canada • Aim: Symptom relief
Last updated Aug 19, 2026 00:00 UTC
-
New Triple-Action drug takes on Hard-to-Treat cancers
Disease control Recruiting nowThis study is an open-label first-in-human phase I clinical study to evaluate the safety, tolerability, and pharmacokinetic characteristics of HLX3902 in patients with mCRPC and other advanced solid tumours.
Phase 1 • Sponsor: Shanghai Henlius Biotech • Aim: Disease control
Last updated Aug 13, 2026 00:00 UTC
-
New drug aims to lighten heavy periods for bleeding disorder patients
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, efficacy, and pharmacodynamics (PD) of multiple doses of ALN-6400 in adult and adolescent patients with VWD and HMB
Phase 2 • Sponsor: Alnylam Pharmaceuticals • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New RNA drug takes on tough liver tumors
Disease control Not yet recruitingPrimary liver cancer (Hepatocellular carcinoma, HCC) represents a major challenge in clinical oncology and poses a serious threat to public health. In recent years, the application of immune checkpoint inhibitors (ICIs) has transformed the landscape of cancer therapy, demonstrati…
Phase 1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New injection aims to tackle hidden heart risk
Disease control Not yet recruitingThe purpose of this study is to evaluate the efficacy and safety of SYH2068 injection in patients with elevated lipoprotein(a).
Phase 2 • Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC